Technology | Breast Density | April 13, 2018

Densitas Receives FDA Clearance for PACS-Centric Breast Density Software

Machine learning breast density software empowers radiologists with on-demand, actionable insights

Densitas Receives FDA Clearance for PACS-Centric Breast Density Software

April 13, 2018 — Densitas Inc. has received U.S. Food and Drug Administration (FDA) clearance for its DENSITAS|density automated breast density software. The software analyzes the same processed digital mammograms that radiologists view and are routinely stored in picture archiving and communication systems (PACS).

The zero-click software provides radiologists with breast density assessments at point-of-care that are as accurate as the visual assessments made by experienced Mammography Quality Standards Act (MQSA)-qualified radiologists. The automated reports enhance confidence in follow-up care decisions and facilitate uniformity in density measurements across clinics and major hospital networks. The company said DENSITAS|density integrates seamlessly with PACS and enhances workflow.  

Densitas has the advantage of generating breast density assessments from standard processed breast images and their priors that are stored in PACS. This provides a practical solution for integrating breast density into risk-based models in population-based screening.

DENSITAS|density is cleared for clinical use in the U.S., Europe, Canada and Australia, and is the first of several follow-on products. The software is being showcased at the 2018 Society for Breast Imaging (SBI)/American College of Radiology (ACR) Breast Imaging Symposium, April 12-15, in Las Vegas.

For more information: www.densitas.health

 

Related Content

Sponsored Content | Case Study | Enterprise Imaging | November 16, 2018
Centricity Clinical Archive Analytics uses Microsoft Azure and Power BI Embedded to derive intelligence from the data
Feature | November 16, 2018 | By Greg Freiherr
For the first time at the RSNA meeting, vendors of interventiona
Podcast | Interventional Radiology | November 16, 2018
For the first time at the RSNA meeting, vendors of interventional products will have a dedicated area in which to dis
Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Life Image and Mendel.ai Bringing Artificial Intelligence to Clinical Trial Development
News | Artificial Intelligence | November 15, 2018
Life Image and Mendel.ai announced a new strategic partnership that will facilitate the adoption and enhancement of...
News | Enterprise Imaging | November 14, 2018
Konica Minolta Healthcare Americas Inc. will showcase new features and tools for the Exa Enterprise Imaging platform at...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
SuperSonic Imagine Introduces Aixplorer Mach 30 Ultrasound at The Liver Meeting
Technology | Ultrasound Imaging | November 14, 2018
SuperSonic Imagine recently exhibited at The Liver Meeting, held Nov. 9-13 in San Francisco, where the company...